474 related articles for article (PubMed ID: 18634036)
1. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.
Perugorria MJ; Latasa MU; Nicou A; Cartagena-Lirola H; Castillo J; Goñi S; Vespasiani-Gentilucci U; Zagami MG; Lotersztajn S; Prieto J; Berasain C; Avila MA
Hepatology; 2008 Oct; 48(4):1251-61. PubMed ID: 18634036
[TBL] [Abstract][Full Text] [Related]
2. The epidermal growth factor receptor ligand amphiregulin is a negative regulator of hepatic acute-phase gene expression.
Pardo-Saganta A; Latasa MU; Castillo J; Alvarez-Asiain L; Perugorría MJ; Sarobe P; Rodriguez-Ortigosa CM; Prieto J; Berasain C; Santamaría M; Avila MA
J Hepatol; 2009 Dec; 51(6):1010-20. PubMed ID: 19815304
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesis.
Kao YH; Chen CL; Jawan B; Chung YH; Sun CK; Kuo SM; Hu TH; Lin YC; Chan HH; Cheng KH; Wu DC; Goto S; Cheng YF; Chao D; Tai MH
J Hepatol; 2010 Jan; 52(1):96-105. PubMed ID: 19913322
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells.
Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W
Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: potential novel players in the progression of liver injury.
Berasain C; Sampedro A; Mauleón I; Goñi S; Latasa MU; Matscheko N; García-Bravo M; Unzu C; Corrales FJ; Enríquez de Salamanca R; Prieto J; Avila MA; Fontanellas A
Cell Mol Biol (Noisy-le-grand); 2009 Feb; 55(1):29-37. PubMed ID: 19267999
[TBL] [Abstract][Full Text] [Related]
8. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of connective tissue growth factor and type I collagen mRNA expression by connective tissue growth factor antisense oligonucleotide during experimental liver fibrosis.
Uchio K; Graham M; Dean NM; Rosenbaum J; Desmoulière A
Wound Repair Regen; 2004; 12(1):60-6. PubMed ID: 14974966
[TBL] [Abstract][Full Text] [Related]
10. C/EBP-α ameliorates CCl(4)-induced liver fibrosis in mice through promoting apoptosis of hepatic stellate cells with little apoptotic effect on hepatocytes in vitro and in vivo.
Tao LL; Cheng YY; Ding D; Mei S; Xu JW; Yu J; Ou-Yang Q; Deng L; Chen Q; Li QQ; Xu ZD; Liu XP
Apoptosis; 2012 May; 17(5):492-502. PubMed ID: 22307857
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus (HCV) protein expression enhances hepatic fibrosis in HCV transgenic mice exposed to a fibrogenic agent.
Chouteau P; Defer N; Florimond A; Caldéraro J; Higgs M; Gaudin A; Mérour E; Dhumeaux D; Lerat H; Pawlotsky JM
J Hepatol; 2012 Sep; 57(3):499-507. PubMed ID: 22613003
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
13. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells.
Castillo J; Erroba E; Perugorría MJ; Santamaría M; Lee DC; Prieto J; Avila MA; Berasain C
Cancer Res; 2006 Jun; 66(12):6129-38. PubMed ID: 16778186
[TBL] [Abstract][Full Text] [Related]
14. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
15. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm.
Gressner AM; Bachem MG
Ann Biol Clin (Paris); 1994; 52(3):205-26. PubMed ID: 7998677
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptor 1 knockout reduces experimentally induced liver fibrosis.
Rullier A; Gillibert-Duplantier J; Costet P; Cubel G; Haurie V; Petibois C; Taras D; Dugot-Senant N; Deleris G; Bioulac-Sage P; Rosenbaum J
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G226-35. PubMed ID: 17962354
[TBL] [Abstract][Full Text] [Related]
17. Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis.
Huang CK; Lee SO; Lai KP; Ma WL; Lin TH; Tsai MY; Luo J; Chang C
Hepatology; 2013 Apr; 57(4):1550-63. PubMed ID: 23150236
[TBL] [Abstract][Full Text] [Related]
18. Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells.
De Minicis S; Seki E; Oesterreicher C; Schnabl B; Schwabe RF; Brenner DA
Hepatology; 2008 Dec; 48(6):2016-26. PubMed ID: 19025999
[TBL] [Abstract][Full Text] [Related]
19. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
Gressner AM
Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
[TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice.
Latella G; Vetuschi A; Sferra R; Catitti V; D'Angelo A; Zanninelli G; Flanders KC; Gaudio E
Liver Int; 2009 Aug; 29(7):997-1009. PubMed ID: 19422482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
